levodopa/carbidopa

Developed for: movement disorder · Parkinson disease
Investigated by: Swedish Parkinson's Disease Foundation · Swedish Society for Medical Research · Uppsala University

today NCT00888186 · Ph 4

20082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT00888186	Feb → May 2008	Parkinson disease, movement disorder	Uppsala University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	levodopa/carbidopa	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00888186 ↗
Route	Other	“duodenal infusion” NCT00888186 ↗